INTERNATIONAL PATENT: XADCERA BIOPHARMACEUTICAL (SUZHOU) CO., LTD. FILES APPLICATION FOR "USE OF ANTI-HER3/MUC1 ANTIBODIES IN CANCER THERAPY"

GENEVA, March 2 -- XADCERA BIOPHARMACEUTICAL (SUZHOU) CO., LTD. (Room 301, Building C29, 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123) filed a patent application (PCT/CN2025/115757) for "USE OF ANTI-HER3/MUC1 ANTIBODIES IN CANCER THERAPY" on Aug 20, 2025. With publication no. WO/2026/041029, the details related to the patent application was published on Feb 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Yifu (Room 301, Building C29, 218 Xinghu Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), LI, Zhuolin (Room 301, Building C29, 218 Xinghu Street, Suzhou I...